ror2 promoter methylation change in osteoblastic differentiation of mesenchymal stem cells
نویسندگان
چکیده
objective: osteoblasts arise from multipotent mesenchymal stem cells (mscs) present in the bone marrow stroma and undergo further differentiation to osteocytes or bone cells. many factors such as proteins present in the wnt signaling pathway affect osteoblast differentiation. ror2 is an orphan tyrosine kinase receptor that acts as a co-receptor in the non-canonical wnt signaling pathway. however, ror2 has been shown to be regulated by both canonical and non-canonical wnt signaling pathways. ror2 expression increases during differentiation of mscs to osteoblasts and then decreases as cells differentiate to osteocytes. on the other hand, research has shown that ror2 changes msc fate towards osteoblasts by inducing osteogenic transcription factor osterix. here we speculated whether ror2 gene expression regulation during osteoblastogenesis is epigenetically determined. materials and methods: mscs from bone marrow were isolated, expanded and characterized in vitro according to standard procedures. ror2 promoter methylation status was determined using methylation specific pcr in a multipotent state and during differentiation to osteoblasts. results: we determined that the demethylation process in ror2 promoter occurs during the differentiation process. the process of demethylation begins at day 8 and continues until 21 days of differentiation. conclusion: this result is in concordance with previous works on the role of ror2 on osteoblast differentiation, which have shown an upregulation of ror2 expression during this process.
منابع مشابه
ROR2 Promoter Methylation Change in Osteoblastic Differentiation of Mesenchymal Stem Cells
OBJECTIVE Osteoblasts arise from multipotent mesenchymal stem cells (MSCs) present in the bone marrow stroma and undergo further differentiation to osteocytes or bone cells. Many factors such as proteins present in the Wnt signaling pathway affect osteoblast differentiation. ROR2 is an orphan tyrosine kinase receptor that acts as a co-receptor in the non-canonical Wnt signaling pathway. However...
متن کاملEvaluation of Changes in Global DNA Methylation during Osteoblastic Differentiation of Mesenchymal Stem Cells: A Laboratory Study
Background and Objectives: Control processes in osteoblastic differentiation of mesenchymal stem cells are not yet fully understood. Epigenetic mechanisms, especially the methylation of CpG Islands in the promoter of genes, are considered as one of the most important control mechanisms in stem cell differentiation. In the process of differentiation, it is debated whether only the methylation of...
متن کاملdifferent methylation patterns of runx2, osx, dlx5 and bsp in osteoblastic differentiation of mesenchymal stem cells
objective: runt-related transcription factor 2 (runx2) and osterix (osx) as two specific osteoblast transcription factors and distal-less homeobox 5 (dlx5) as a non-specific one are of paramount importance in regulating osteoblast related genes including osteocalcin, bone sialoprotein (bsp), osteopontin and collagen type iα1. the present study sets out to investigate whether epigenetic regulati...
متن کاملdoes dna methylation plays a critical role in osteoblastic differentiation of mesenchymal stem cells (mscs)?
متن کامل
Different Methylation Patterns of RUNX2, OSX, DLX5 and BSP in Osteoblastic Differentiation of Mesenchymal Stem Cells
OBJECTIVE Runt-related transcription factor 2 (RUNX2) and osterix (OSX) as two specific osteoblast transcription factors and distal-less homeobox 5 (DLX5) as a non-specific one are of paramount importance in regulating osteoblast related genes including osteocalcin, bone sialoprotein (BSP), osteopontin and collagen type Iα1. The present study sets out to investigate whether epigenetic regulatio...
متن کاملDoes DNA Methylation Plays a Critical Role in Osteoblastic Differentiation of Mesenchymal Stem Cells (MSCs)?
1 Research Center of Thalassemia and Hemoglobinopathy, Jundishapur University of Medical Sciences, Ahvaz, IR Iran 2 Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran 3 Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, Netherlands 4 Young Researchers Club, Science and Research Branch, Islamic Azad U...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
cell journalجلد ۱۳، شماره ۱، صفحات ۱۱-۱۸
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023